146 related articles for article (PubMed ID: 38620465)
1. [Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection].
Barrachina-Esteve O; Palau Domínguez A; Hidalgo-Torrico I; Viguera Martínez ML
Neurologia; 2020; 35(9):710-712. PubMed ID: 38620465
[No Abstract] [Full Text] [Related]
2. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
Front Immunol; 2021; 12():674922. PubMed ID: 34040615
[TBL] [Abstract][Full Text] [Related]
3. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient.
Frank CHM; Almeida TVR; Marques EA; de Sousa Monteiro Q; Feitoza PVS; Borba MGS; Vasconcelos HL; de Souza Bastos M; Lacerda MVG
J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32653906
[TBL] [Abstract][Full Text] [Related]
5. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
[TBL] [Abstract][Full Text] [Related]
6. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
Gaál T; Szeszák G; Torák G; Salacz P
Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report.
Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO
J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002
[TBL] [Abstract][Full Text] [Related]
8. Guillain Barre Syndrome following delivery in a pregnant woman infected with SARS-CoV-2.
Tekin AB; Zanapalioglu U; Gulmez S; Akarsu I; Yassa M; Tug N
J Clin Neurosci; 2021 Apr; 86():190-192. PubMed ID: 33775326
[TBL] [Abstract][Full Text] [Related]
9. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome.
Lunn MP; Carr AC; Keddie S; Pakpoor J; Pipis M; Willison HJ
Brain; 2021 Jun; 144(5):e47. PubMed ID: 33822006
[No Abstract] [Full Text] [Related]
10. Association of Guillain-Barre Syndrome and SARS COV 2 Infection in a Child: First Case Report from India.
Kumar D; Gupta G; Jhamb U
J Pediatr Neurosci; 2021; 16(4):347-349. PubMed ID: 36531763
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome associated with Covid-19: A close relationship or just a coincidence? (Review).
Stoian A; Bălașa R; Grigorescu BL; Maier S; Andone S; Cocuz IG; Bajko Z; Filep CR; Stoian M
Exp Ther Med; 2021 Sep; 22(3):916. PubMed ID: 34306190
[TBL] [Abstract][Full Text] [Related]
12. Post SARS-CoV-2 Guillain-Barré syndrome in a child: case report and review of the literature.
Al Jaberi M; Shihadat R; Masri A
Childs Nerv Syst; 2022 Oct; 38(10):2011-2016. PubMed ID: 35461356
[TBL] [Abstract][Full Text] [Related]
13. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Infection and Guillain-Barré Syndrome.
Makhluf H; Madany H
Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451400
[TBL] [Abstract][Full Text] [Related]
15. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report.
Farzi MA; Ayromlou H; Jahanbakhsh N; Bavil PH; Janzadeh A; Shayan FK
J Neuroimmunol; 2020 Jun; 346():577294. PubMed ID: 32590125
[TBL] [Abstract][Full Text] [Related]
17. Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study.
Hafsteinsdóttir B; Dalemo E; Elíasdóttir Ó; Ólafsson E; Axelsson M
Neuroepidemiology; 2023; 57(1):1-6. PubMed ID: 36366822
[TBL] [Abstract][Full Text] [Related]
18. NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome.
Morsy S
Med Hypotheses; 2020 Dec; 145():110342. PubMed ID: 33069093
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report.
Nigatu D; Tigabu T; Awraris M; Yohannes A; Kebede D
Ethiop J Health Sci; 2022 Jan; 32(1):205-208. PubMed ID: 35250231
[TBL] [Abstract][Full Text] [Related]
20. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
